Categories: News

Nephros to Present at the LD Micro Main Event

SOUTH ORANGE, NJ, Oct. 05, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing innovative filtration and pathogen detection solutions to healthcare and commercial markets, today announced it has been selected to present at the 14th Annual LD Micro Main Event on Tuesday, October 12, 2021 at 12:30 pm ET at the Luxe Sunset Bel-Air in Los Angeles. The Nephros presentation will be delivered by CEO, Andy Astor.

For more information about the LD Micro Main Event, please visit: https://www.meetmax.com/sched/event_76871/conference_home.html

About Nephros
Nephros, Inc. is a company committed to improving the human relationship with water through leading, accessible technology. We provide innovative filtration and pathogen detection as part of an integrated approach to water safety that combines science, solutions, and support services. Nephros products serve the needs of customers within the healthcare and commercial markets, offering both proactive and emergency responses for water management. For more information about Nephros, please visit www.nephros.com.

About LD Micro 
LD Micro aims to be the most crucial resource in the micro-cap world. Whether it is the index, comprehensive data, or hosting the most significant events on an annual basis, LD’s sole mission is to serve as an invaluable asset for all those interested in finding the next generation of great companies. For more information about LD Micro, visit:http://www.ldmicro.com

Investor Relations Contacts:
Kirin Smith, President
PCG Advisory, Inc.
(646) 823-8656
ksmith@pcgadvisory.com

Andy Astor, CEO
Nephros, Inc.
(201) 345-0824
andy@nephros.com

Staff

Recent Posts

SHOWCASING TOMORROW’S INNOVATORS: LG NOVA RETURNS TO CES 2025

LG NOVA Pushes Forward the Future of Collaboration and Innovation Across Healthtech, AI and Cleantech…

2 hours ago

AEON Biopharma, Inc. Announces Launch of Proposed Public Offering

IRVINE, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”)…

11 hours ago

Oculis Publishes Notification of Major Changes in Voting Rights

ZUG, Switzerland, Jan. 04, 2025 (GLOBE NEWSWIRE) -- Attached is a Notification of Major Changes…

11 hours ago

ARCPOINT CLOSES SALE OF OWNERSHIP STAKE IN NON-CORE ASSET

Greenville, South Carolina , Jan. 03, 2025 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the…

11 hours ago

Palisade Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Carlsbad, CA, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc.  (Nasdaq: PALI) (“Palisade”, “Palisade…

11 hours ago

PharmaTher Announces Grant of Stock Options

TORONTO, Jan. 03, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB:…

11 hours ago